Cravath represented RedHill in connection with the transaction. RedHill Biopharma Ltd. (“RedHill”), a specialty biopharmaceutical company, announced the extinguishment of all RedHill’s debt obligations (including all...
RedHill’s Agreement with HealthCare Royalty to Extinguish Debt Obligations in Exchange for Movantik
WiseTech Global’s $230 Million Acquisition of Envase Technologies
Cravath represented WiseTech Global in the transaction. WiseTech Global, developer of leading logistics execution software CargoWise, announced its acquisition of Envase Technologies (“Envase”), a leading provider...
Vaxxinity’s $89.7 Million Initial Public Offering
Cravath represented Vaxxinity in the transaction. Vaxxinity, Inc. executed its initial public offering of 6,000,000 shares of class A common stock at a public offering price of $13.00...